Daunorubicin and daunorubicinol tissue concentrations in gastric cancer patients after local administration of a liposomal preparation.

Furlanut, M; de Manzoni, G; Pasini, F; Tasselli, S; Tomezzoli, A; Poz, D; Franceschi, L

Furlanut, M; de Manzoni, G; Pasini, F; Tasselli, S; Tomezzoli, A; Poz, D; Franceschi, L.

Affiliation

Furlanut M; Institute of Clinical Pharmacology and Toxicology, DPMSC, University of Udine, Italy. mario.furlanut@med.uniud.it

Pharmacol Res ; 56(4): 344-9, 2007 Oct.

Article in En | MEDLINE | ID: mdl-17904378

Subject(s)

Antibiotics, Antineoplastic/pharmacokinetics; Daunorubicin/analogs & derivatives; Daunorubicin/pharmacokinetics; Adult; Aged; Antibiotics, Antineoplastic/administration & dosage; Daunorubicin/administration & dosage; Dose-Response Relationship, Drug; Female; Gastric Mucosa; Gastroscopy; Humans; Injections; Injections, Intralesional; Liposomes; Lymph Nodes/metabolism; Male; Middle Aged; Prospective Studies; Stomach Neoplasms/metabolism; Tissue Distribution

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Daunorubicin / Antibiotics, Antineoplastic Type of study: Observational_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Pharmacol Res Year: 2007 Document type: Article

Search on Google

XML

PubMed Links